Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

Health
By Rebecca Robbins from NYT Health https://ift.tt/vVH6BJ9
via IFTTT Appointments and Executive Changes, Drugs (Pharmaceuticals), Ozempic (Drug), GLP-1 RAs (Drug), Stocks and Bonds The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Comments

Post a Comment

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

Image
Health By Christina Jewett and Apoorva Mandavilli from NYT Health https://ift.tt/VHvAQN8 via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry, Rumors and Misinformation, Clinical Trials, Medicine and Health Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others may not be able to get the shots.
Read more

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women

Image
Health By Apoorva Mandavilli and Christina Jewett from NYT Health https://ift.tt/lefLSPp via IFTTT Vaccination and Immunization, Children and Childhood, United States Politics and Government, Regulation and Deregulation of Industry, Babies and Infants, Pregnancy and Childbirth, Coronavirus (2019-nCoV) Health Secretary Robert F. Kennedy Jr. announced that the vaccine would not be included as part of the immunization schedule for healthy children.
Read more